The global software as a medical device (SaMD) market is valued at USD 1.8 billion in 2024 and is forecasted to expand at a compound annual growth rate (CAGR) of 13%, reaching USD 6.1 billion by 2034. This remarkable growth is driven by the increasing integration of artificial intelligence (AI) and machine learning (ML) in healthcare, rising prevalence of chronic diseases, and supportive government initiatives promoting digital health solutions. SaMD refers to software intended for medical purposes, such as diagnosis, monitoring, or treatment, without being part of a hardware medical device.
For More Insights into the Market, Request a Sample of this Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=7679
It runs on general-purpose platforms like smartphones, laptops, and wearables, enabling applications in screening, disease management, and digital therapeutics. The market’s expansion reflects the digital health revolution, accelerated by the COVID-19 pandemic, which boosted telehealth adoption by 38 times in the U.S. alone, emphasizing the need for accessible, data-driven medical tools.
Market Segmentation and Trends:
The SaMD market is segmented by device type, application, software technology, and region. Device types include smartphones (44% market share by 2034, valued at USD 700 million in 2024, growing at 14.1% CAGR), laptops/desktops, and wearable devices, with smartphones leading due to their ubiquity and integration with AI for real-time health monitoring. Applications encompass screening & diagnosis (46% revenue share in 2024, reaching USD 2.5 billion by 2034 at 12% CAGR), monitoring & alerting, chronic conditions & disease management, and digital therapeutics, with screening & diagnosis dominating for its role in early detection using advanced algorithms. Software technologies focus on AI and ML, enabling predictive analytics and personalized care.
Regional segments include North America, Europe, Asia Pacific, Latin America, and Middle East & Africa (MEA). Key trends include the proliferation of AI-driven apps for decision-making, IoT integration with wearables for continuous data collection, and 5G-enabled real-time diagnostics. The rise of digital therapeutics, approved by regulators like the FDA, and consumer acceptance of mobile health apps (500 million downloads in 2023) are reshaping the landscape.
Driving Factors Behind Market Growth:
Several factors are propelling market expansion. The growing burden of chronic diseases, affecting 1.7 billion people globally (WHO 2023), drives demand for SaMD in management and monitoring, reducing healthcare costs by 20% through remote solutions. Government initiatives, such as the U.S. FDA’s Digital Health Innovation Action Plan and EU’s Medical Device Regulation, foster innovation and regulatory clarity, boosting investments to USD 6 billion in digital health startups in 2023. AI and ML advancements enable precise diagnostics, with algorithms improving accuracy by 15-20% in imaging and predictive modeling.
The aging population, projected to reach 1.5 billion over 65 by 2050, heightens needs for wearable-based monitoring. Rising smartphone penetration (6.6 billion users) and 5G deployment facilitate seamless data transmission, enhancing user adoption. Consumer awareness of digital health, amplified by social media and apps like Fitbit, further fuels growth.
Recent Developments and Key Players:
The market is competitive, with players emphasizing AI and acquisitions. In 2021, Star acquired Pro 4 People to enhance MedTech solutions, expanding its SaMD offerings. Key players include GE Healthcare, iCAD Inc., Hyperfine Research, Star, Tietronix Software, Inc., S3 Connected Health, Ideagen, BrightInsight, Inc., Inzentiz, Zühlke Group, and Orthogonal. These companies invest in AI platforms, with GE Healthcare launching AI-driven imaging software in 2023, improving diagnostic speed by 30%.
Competitor analysis highlights a focus on interoperability. Partnerships, like BrightInsight’s collaboration with AstraZeneca for digital therapeutics, strengthen portfolios. Smaller players like Orthogonal target regulatory compliance tools, while major firms leverage global networks for healthcare contracts. The market sees rising adoption of open-source frameworks for cost-effective development.
Browse Full Report: https://www.factmr.com/report/software-as-a-medical-device-market
Regional Insights and Opportunities:
North America holds a 24.3% share by 2034 (CAGR 13.2%), driven by the U.S. (USD 200 million in 2024 to USD 700 million by 2034 at 13.5% CAGR) with FDA approvals accelerating innovation. East Asia reaches USD 1.4 billion by 2034, with Japan at USD 100 million in 2024 to USD 400 million (13.5% CAGR) due to an aging population and tech-savvy consumers. China is valued at USD 700 million by 2034. Europe, led by Germany, benefits from strong regulations. Asia Pacific is fastest-growing, fueled by digital health investments. Opportunities include AI in chronic disease management and expanding in MEA with mobile penetration.
Challenges and Future Outlook:
Challenges include cybersecurity risks, with cybercrime undermining trust, and regulatory hurdles for SaMD classification delaying launches. Insufficient measures against duplicates and ongoing monitoring needs pose barriers. However, the market’s future is promising, with opportunities in AI personalization and emerging markets. By 2034, the SaMD market is expected to more than triple, transforming healthcare through innovative, accessible solutions.
Check out More Related Studies Published by Fact.MR:
Advanced Predictive Analytics Software Market https://www.factmr.com/report/advanced-predictive-analytics-market
Sustainability Energy Management Software Market https://www.factmr.com/report/sustainability-energy-management-software-market
Mental Health Software Market https://www.factmr.com/report/mental-health-software-market
Enterprise Performance Management Software (EPMS) Market https://www.factmr.com/report/enterprise-performance-management-software-market
Robot Software Market https://www.factmr.com/report/robot-software-market
Time Tracking Software Market https://www.factmr.com/report/time-tracking-software-market
Translation Software Market https://www.factmr.com/report/translation-software-market
Audio and Video Editing Software Market https://www.factmr.com/report/audio-and-video-editing-software-market
Contact:
US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583, +353-1-4434-232
Email: sales@factmr.com
About Fact.MR
We are a trusted research partner of 80% of fortune 1000 companies across the globe. We are consistently growing in the field of market research with more than 1000 reports published every year. The dedicated team of 400-plus analysts and consultants is committed to achieving the utmost level of our client’s satisfaction.
This release was published on openPR.
